Promyco Diagnostics

Company Overview

Snapshot

Founded in January 2008, Promyco Diagnostics operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on research and development.

Business overview

Promyco Diagnostics is a Health Tech & Life Sciences company specializing in medical devices and diagnostics. The company develops a simple, non-invasive serology diagnostic kit designed to detect urogenital Mycoplasma infection, thereby assessing women for their risk of developing pregnancy complications. Its core technology is based on a patent-protected mixture of mycoplasmal components, carefully selected from Mycoplasma isolated from patients with active inflammation, to create a highly sensitive and specific serology test. Promyco Diagnostics primarily serves the healthcare and women's health markets.

Company Intelligence Q&A

What is Promyco Diagnostics' primary focus?

Promyco Diagnostics focuses on high-risk pregnancy assessment through the development of a non-invasive serology diagnostic kit for detecting urogenital Mycoplasma infection.

When was Promyco Diagnostics founded?

Promyco Diagnostics was founded in January 2008.

What is the core technology behind Promyco Diagnostics' diagnostic kit?

The core technology of Promyco Diagnostics' kit is based on a patent-protected mixture of mycoplasmal components (antigens), selected from Mycoplasma isolated from patients with active inflammation, to ensure high sensitivity and specificity.

In which sector does Promyco Diagnostics primarily operate?

Promyco Diagnostics operates primarily in the Health Tech & Life Sciences sector, specifically within medical devices and diagnostics.

What is the current stage of Promyco Diagnostics' product development?

Promyco Diagnostics' product is currently in the Research and Development (R&D) stage, focusing on developing a non-invasive serology diagnostic kit for detecting urogenital Mycoplasma infection.